Cargando…

Role of mepolizumab in severe allergic asthma with vocal cord polyp

Interleukin (IL)-5 plays an important role in development, recruitment, and survival of eosinophils, thereby causing debilitating signs and symptoms associated with severe eosinophilic asthma. Mepolizumab is a humanized monoclonal antibody (mAb) against IL-5 which selectively inhibits eosinophilic i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Azmat, Shameem, Mohammd, Khan, Abdul Allam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746279/ https://www.ncbi.nlm.nih.gov/pubmed/36629239 http://dx.doi.org/10.4103/lungindia.lungindia_272_22

Ejemplares similares

Cryoablation of vocal cord polyp
por: Chawla, Rakesh K, et al.
Publicado: (2021)

Effect of benralizumab in a patient with uncontrolled severe eosinophilic asthma and comorbid chronic rhinosinusitis with nasal polyps refractory to mepolizumab treatment
por: Mansur, Adel H.
Publicado: (2021)

Recovery of smell sense loss by mepolizumab in a patient allergic to Dermatophagoides and affected by chronic rhinosinusitis with nasal polyps
por: Cavaliere, Carlo, et al.
Publicado: (2019)

Mepolizumab in allergic bronchopulmonary aspergillosis complicated by infection
por: Hamada, Toru, et al.
Publicado: (2023)

A Giant Vocal Cord Polyp Mimics Asthma Attack
por: Chida, Yasuyuki, et al.
Publicado: (2018)

Severe Pediatric Asthma Therapy: Mepolizumab
por: Ullmann, Nicola, et al.
Publicado: (2022)

Eosinophils depletion therapy for severe asthma management following favorable response to mepolizumab
por: Matsuno, Osamu, et al.
Publicado: (2019)

Three cases of severe adolescent asthma treated with mepolizumab: lung function trajectories
por: Hoshi, Miyuki, et al.
Publicado: (2020)

A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab
por: Terashima, Takeshi, et al.
Publicado: (2018)

Mepolizumab use in cystic fibrosis‐associated allergic bronchopulmonary aspergillosis
por: Boyle, Maeve, et al.
Publicado: (2020)

Vocal Polyps in Tourette Syndrome
por: Chu, Michael P, et al.
Publicado: (2011)

Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Mukherjee, Manali, et al.
Publicado: (2017)

Successful Treatment of Mepolizumab- and Prednisolone-resistant Allergic Bronchopulmonary Aspergillosis with Dupilumab
por: Mikura, Sunao, et al.
Publicado: (2021)

Clinical usefulness of mepolizumab in severe eosinophilic asthma
por: Menzella, Francesco, et al.
Publicado: (2016)

Real-Life Performance of Mepolizumab in T2-High Severe Refractory Asthma with the Overlapping Eosinophilic-Allergic Phenotype
por: González-Pérez, Ruperto, et al.
Publicado: (2022)

Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature
por: Hirota, Shuko, et al.
Publicado: (2018)

Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab
por: Matsumoto, Nobuhiro, et al.
Publicado: (2019)

Successful and safe treatment of severe steroid depended eosinophilic asthma with mepolizumab in a woman during pregnancy
por: Vittorakis, Stylianos K., et al.
Publicado: (2022)

Severe asthma remaining well‐controlled after mepolizumab discontinuation: A case report and literature review
por: Matsuyama, Takahiro, et al.
Publicado: (2023)

Efficacy of add-on mepolizumab in adolescents with severe eosinophilic asthma
por: Yancey, Steven W., et al.
Publicado: (2019)

Lessons Learned from A Case of Functional Total Laryngeal Obstruction Under Anaesthesia by Vocal Cord Polyp Managed by Vortex Approach
por: Kurwe, Mahesh S, et al.
Publicado: (2021)

Refractory flare-up of severe bronchial asthma controlled with mepolizumab due to Pneumocystis pneumonia: a case report
por: Takeda, Kazuya, et al.
Publicado: (2022)

A patient case demonstrating the efficacy of benralizumab in uncontrolled severe eosinophilic asthma refractory to omalizumab and mepolizumab treatment
por: Davison, John, et al.
Publicado: (2021)

Near-fatal asthma responsive to mepolizumab after failure of omalizumab and bronchial thermoplasty
por: Menzella, Francesco, et al.
Publicado: (2017)

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India
por: Maturu, Venkata Nagarjuna, et al.
Publicado: (2021)

Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection
por: Tsubouchi, Hironobu, et al.
Publicado: (2019)

Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
por: Haldar, Pranabashis
Publicado: (2017)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
por: Numata, Takanori, et al.
Publicado: (2019)

Mepolizumab does not alter the blood basophil count in severe asthma
por: Wright, Adam Kelvin Alec, et al.
Publicado: (2019)

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
por: Caruso, C., et al.
Publicado: (2020)

Mepolizumab asthma treatment failure due to refractory airway eosinophilia, which responded to benralizumab
por: Cook, Alistair, et al.
Publicado: (2021)

Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
por: Pelaia, Corrado, et al.
Publicado: (2017)

Asthma mimic: Case report and literature review of vocal cord nodule associated with wheezing
por: Kashif, Muhammad, et al.
Publicado: (2017)

Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study
por: Detoraki, Aikaterini, et al.
Publicado: (2021)

Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma
por: Howarth, Peter, et al.
Publicado: (2020)

Self-Administered Mepolizumab in the Management of Severe Asthma: Usability and Patient Acceptance
por: Miyokawa, Reika, et al.
Publicado: (2020)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()
por: Bagnasco, Diego, et al.
Publicado: (2021)

Response to Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma and Atopic Phenotypes
por: Prazma, Charlene M, et al.
Publicado: (2021)

Outcomes over the first two years of treatment with mepolizumab in severe asthma
por: Elsey, Lynn, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6j30f7l463ihaiamd9s7577rdu